BCL2 and in situ carcinoma: A similar effect was observed in Bcl-2 and Bcl-XL anti-apoptotic proteins when SiHaP and SiHaCIS-R cells were treated with PTX or PTX + CIS (Figures 4C–F; p < 0.001).